Cancer Cachexia Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Cancer Cachexia Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Feb 2018 Transparency Market Research Pharmaceutical218 Pages Price :
$ 5795

 

Global Cancer Cachexia Market: Overview

This report on the cancer cachexia market analyzes the current and future scenario of the global market. Growth of the global cancer cachexia market is driven by high investments made in cutting-edge drug research resulting in new, sophisticated treatments with specific mechanism of action. Moreover, rising emphasis on palliative cancer care will further boost the market in near future. The cancer cachexia market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market.

It also provides information and data analysis of the global market with respect to the segments based on therapeutics, mechanism of action, distribution channel, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the cancer cachexia market.

Global Cancer Cachexia Market: Segmentation

The global cancer cachexia market has been analyzed on the basis of therapeutics, mechanism of action, distribution channels and geography. Major therapeutics segments are progestogens, corticosteroids combination therapies, others. The others segment of global cancer cachexia market includes pipeline therapeutic approach. Thus the market of others segment has been considered as addressable market. According to mechanism of action, market is segmented in to appetite stimulators, weight loss stabilizers, and other mode of actions. Hospital stores, retail pharmacy stores, online pharmacy are considered as preferred distribution channels.

The market is driven by argumentative lifestyle habits leading to lung cancer, rising incidence rate of cachexia mainly in the developed region like the U.S., Europe and Japan. Moreover, increasing funding for cancer research by government and private organizations, increased awareness about palliative care will further the demand for cancer cachexia drugs in near future. While, stringent regulatory requirements and long procedure for FDA approval have discouraged cancer cachexia drug manufacturers. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Cancer Cachexia Market: Regional Outlook

Geographically, the global cancer cachexia market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global cancer cachexia market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players in the women’s health market are – Æterna Zentaris Inc., Alder BioPharmaceuticals Inc., Aphios Corporation, Eli Lilly and Company, GTx, Inc., Helsinn Group, Merck & Co., Inc., Novartis AG, Bristol-Myers Squibb Company, and XBiotech, Inc.

The global cancer cachexia market has been segmented as follows:

By Therapeutics

  • Progestogens
  • Corticosteroids
  • Combination Therapies
  • Others

By Mechanism of action

  • Appetite Stimulators
  • Weight Loss Stabilizers
  • Others

By Distribution Channel

  • Hospital Stores
  • Retail Pharmacy Stores
  • Online Pharmacy

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia and New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of MEA

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives

2. Assumptions and Research Methodology

3. Executive Summary: Global Cancer Cachexia Market 

4. Market Overview
4.1. Introduction
4.1.1. Therapeutics Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.5. Global Cancer Cachexia Market Analysis and Forecasts, 2014-2024
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Cancer Cachexia Market - Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Regulatory Scenario
4.9. Cancer Cachexia – Incidence Rate
4.10. Cancer Cachexia – Therapeutic Approach
4.11. Cancer Cachexia Market: Pipeline Analysis
4.11.1. Phase III drugs (Forecast from approval year to 2024)
4.11.2. Phase I and Phase II drugs (Qualitative Information)

5. Global Cancer Cachexia Market Analysis and Forecasts, By Therapeutics 
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast by Therapeutics, 2015–2025
5.4.1. Progestogens
5.4.2. Corticosteroids
5.4.3. Combination therapies
5.5. Market Attractiveness by Therapeutics
 
6. Global Cancer Cachexia Market Analysis and Forecasts, By Mechanism of action 
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast by Mechanism of action, 2015–2025
6.4.1. Appetite Stimulators
6.4.2. Weight loss stabilizers
6.4.3. Others
6.5. Market Attractiveness by Mechanism of action 

7. Global Cancer Cachexia Market Analysis and Forecasts, By Distribution Channels 
7.1. Introduction & Definition
7.3. Key Trends
7.4. Market Value Forecast by Distribution Channels, 2015–2025
7.4.1. Hospital Stores
7.4.2. Retails Pharmacy Store
7.4.3. Online Pharmacy
7.5. Market Attractiveness by Distribution Channels 

8. Global Cancer Cachexia Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Policies and Regulations
8.3. Market Value Forecast by Region
8.3.1. North America 
8.3.2. Europe 
8.3.3. Asia Pacific 
8.3.4. Latin America 
8.3.5. Middle East and Africa
8.4. Market Attractiveness by Country/Region

9. North America Cancer Cachexia Market Analysis and Forecast
9.1. Introduction
9.1.2. Policies and Regulations
9.1.3. Key Trends
9.2. Market Value Forecast by Therapeutics, 2015–2025
9.2.1. Progestogens
9.2.2. Corticosteroids
9.2.3. Combination therapies
9.3. Market Value Forecast by Mechanism of action, 2015–2025
9.3.1. Appetite Stimulators
9.3.2. Weight loss stabilizers
9.3.3. Others
9.4. Market Value Forecast by Distribution Channels, 
9.4.1. Hospital Stores
9.4.2. Retails Pharmacy Store
9.4.3. Online Pharmacy
9.5. Market Value Forecast by Country, 2015–2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis 
9.6.1. By Therapeutics 
9.6.2. By Mechanism of action 
9.6.3. By Distribution Channels 
9.6.4. By Country

10. Europe Cancer Cachexia Market Analysis and Forecast
10.1. Introduction
10.1.2. Policies and Regulations
10.1.3. Key Trends
10.2. Market Value Forecast by Therapeutics, 2015–2025
10.2.1. Progestogens
10.2.2. Corticosteroids
10.2.3. Combination therapies
10.3. Market Value Forecast by Mechanism of action, 2015–2025
10.3.1. Appetite Stimulators
10.3.2. Weight loss stabilizers
10.3.3. Others
10.4. Market Value Forecast by Distribution Channels, 
10.4.1. Hospital Stores
10.4.2. Retails Pharmacy Store
10.4.3. Online Pharmacy
10.5. Market Value Forecast by Country, 2015–2025
10.5.1. U.K.
10.5.2. Germany
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Russia
10.5.7. Rest of Europe
10.6. Market Attractiveness Analysis 
10.6.1. By Therapeutics 
10.6.2. By Mechanism of action 
10.6.3. By Distribution Channels 
10.6.4. By Country

11. Asia-Pacific Cancer Cachexia Market Analysis and Forecast
11.1. Introduction
11.1.1. Policies and Regulations
11.1.2. Key Trends
11.2. Market Value Forecast by Therapeutics, 2015–2025
11.2.1. Progestogens
11.2.2. Corticosteroids
11.2.3. Combination therapies
11.3. Market Value Forecast by Mechanism of action, 2015–2025
11.3.1. Appetite Stimulators
11.3.2. Weight loss stabilizers
11.3.3. Others
11.4. Market Value Forecast by Distribution Channels, 
11.4.1. Hospital Stores
11.4.2. Retails Pharmacy Store
11.4.3. Online Pharmacy
11.5. Market Value Forecast by Country, 2015–2025
11.5.1. India
11.5.2. China
11.5.3. Japan
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia-Pacific
11.6. Market Attractiveness Analysis 
11.6.1. By Therapeutics 
11.6.2. By Mechanism of action 
11.6.3. By Distribution Channels 
11.6.4. By Country

12. Latin America Cancer Cachexia Market Analysis and Forecast
12.1. Introduction
12.1.2. Policies and Regulations
12.1.3. Key Trends
12.2. Market Value Forecast by Therapeutics, 2015–2025
12.2.1. Progestogens
12.2.2. Corticosteroids
12.2.3. Combination therapies
12.3. Market Value Forecast by Mechanism of action, 2015–2025
12.3.1. Appetite Stimulators
12.3.2. Weight loss stabilizers
12.3.3. Others
12.4. Market Value Forecast by Distribution Channels, 
12.4.1. Hospital Stores
12.4.2. Retails Pharmacy Store
12.4.3. Online Pharmacy
12.5. Market Value Forecast by Country, 2015–2025
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis 
12.6.1. By Therapeutics 
12.6.2. By Mechanism of action 
12.6.3. By Distribution Channels 
12.6.4. By Country

13. Middle East and Africa Cancer Cachexia Market Analysis and Forecast
13.1. Introduction
13.1.2. Policies and Regulations
13.1.3. Key Trends
13.2. Market Value Forecast by Therapeutics, 2015–2025
13.2.1. Progestogens
13.2.2. Corticosteroids
13.2.3. Combination therapies
13.2.4. Others
13.3. Market Value Forecast by Mechanism of action, 2015–2025
13.3.1. Appetite Stimulators
13.3.2. Weight loss stabilizers
13.3.3. Others
13.4. Market Value Forecast by Distribution Channels, 
13.4.1. Hospital Stores
13.4.2. Retails Pharmacy Store
13.4.3. Online Pharmacy
13.5. Market Value Forecast by Country, 2015–2025
13.5.1. South Africa
13.5.2. GCC Countries
13.5.3. Rest of Middle East and Africa
13.6. Market Attractiveness Analysis 
13.6.1. By Therapeutics 
13.6.2. By Mechanism of action 
13.6.3. By Distribution Channels 
13.6.4. By Country

14. Competition Landscape
14.1. Market Competition Analysis by Company (2016)
14.2. Company Profiles
14.2.1. Æterna Zentaris Inc.
14.2.1.1. Overview (HQ, Employee Strength, Business Segments)
14.2.1.2. Financials
14.2.1.3. Recent Development
14.2.1.4. Strategy
14.2.2. Alder BioPharmaceuticals Inc.
14.2.2.1. Overview (HQ, Employee Strength, Business Segments)
14.2.2.2. Financials
14.2.2.3. Recent Development
14.2.2.4. Strategy
14.2.3. Aphios Corporation
14.2.3.1. Overview (HQ, Employee Strength, Business Segments)
14.2.3.2. Financials
14.2.3.3. Recent Development
14.2.3.4. Strategy
14.2.4. Eli Lilly and Company
14.2.4.1. Overview (HQ, Employee Strength, Business Segments)
14.2.4.2. Financials
14.2.4.3. Recent Development
14.2.4.4. Strategy
14.2.5. GTx, Inc.
14.2.5.1. Overview (HQ, Employee Strength, Business Segments)
14.2.5.2. Financials
14.2.5.3. Recent Development
14.2.5.4. Strategy
14.2.6. Helsinn Group
14.2.6.1. Overview (HQ, Employee Strength, Business Segments)
14.2.6.2. Financials
14.2.6.3. Recent Development
14.2.6.4. Strategy
14.2.7. Merck & Co., Inc.
14.2.7.1. Overview (HQ, Employee Strength, Business Segments)
14.2.7.2. Financials
14.2.7.3. Recent Development
14.2.7.4. Strategy
14.2.8. Novartis AG
14.2.8.1. Overview (HQ, Employee Strength, Business Segments)
14.2.8.2. Financials
14.2.8.3. Recent Development
14.2.8.4. Strategy
14.2.9. Bristol-Myers Squibb Company
14.2.9.1. Overview (HQ, Employee Strength, Business Segments)
14.2.9.2. Financials
14.2.9.3. Recent Development
14.2.9.4. Strategy
14.2.10. XBiotech, Inc.
14.2.10.1. Overview (HQ, Employee Strength, Business Segments)
14.2.10.2. Financials
14.2.10.3. Recent Development
14.2.10.4. Strategy

List of Table

Table 01: Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 02: Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 03: Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 04: Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 06: North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 07: North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 08: North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 09: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 10: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 11: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 12: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 13: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 15: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 16: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 17: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 19: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 20: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 21: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 22: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 23: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
Table 24: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025

List of Chart

Figure 01: Global Progestogens Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 02: Global Corticosteroids Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 03: Global Combination Therapies Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 04: Global Cancer Cachexia Market Attractiveness Analysis, by Therapeutics, 2015–2025
Figure 05: Global Cancer Cachexia Market Value (US$ Mn) Share Analysis, by Therapeutics, 2016 and 2025
Figure 06: Global Appetite Stimulators Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 07: Global Weight Loss Stabilizers Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 08: Global Others Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 09: Global Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action, 2015–2025
Figure 10: Global Cancer Cachexia Market Value (US$ Mn) Share Analysis, by Mechanism of Action, 2016 and 2025
Figure 11: Global Hospital Stores Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 12: Global Retail Pharmacy Stores Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 13: Global Online Pharmacy Value Market (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
Figure 14: Global Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel, 2015–2025
Figure 15: Global Cancer Cachexia Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2016 and 2025
Figure 16: Global Cancer Cachexia Market Value Share Analysis, by Region, 2016 and 2025
Figure 17: Global Cancer Cachexia Market Attractiveness Analysis, by Region
Figure 18: North America Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
Figure 19: North America Cancer Cachexia Market Attractiveness Analysis, by Country
Figure 20: North America Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
Figure 21: North America Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 22: North America Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
Figure 23: North America Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 24: North America Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
Figure 25: North America Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
Figure 26: North America Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
Figure 27: Europe Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
Figure 28: Europe Cancer Cachexia Market Attractiveness Analysis, by Country
Figure 29: Europe Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
Figure 30: Europe Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 31: Europe Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
Figure 32: Europe Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 33: Europe Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
Figure 34: Europe Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
Figure 35: Europe Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
Figure 36: Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
Figure 37: Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Country
Figure 38: Asia Pacific Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
Figure 39: Asia Pacific Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 40: Asia Pacific Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
Figure 41: Asia Pacific Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 42: Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
Figure 43: Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
Figure 44: Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
Figure 45: Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
Figure 46: Latin America Cancer Cachexia Market Attractiveness Analysis, by Country
Figure 47: Latin America Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
Figure 48: Latin America Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 49: Latin America Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
Figure 50: Latin America Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 51: Latin America Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
Figure 52: Latin America Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
Figure 53: Latin America Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
Figure 54: Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
Figure 55: Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Country
Figure 56: Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
Figure 57: Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 58: Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
Figure 59: Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 60: Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
Figure 61: Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
Figure 62: Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
Figure 63: Æterna Zentaris, Inc., Net Sales, by Region, 2016
Figure 64: Æterna Zentaris, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 65: Æterna Zentaris, Inc., Breakdown of Net Sales, by Product, 2016
Figure 66: Æterna Zentaris, Inc., Research and Development Cost, 2016 and 2015 (Thousands)
Figure 67: Alder BioPharmaceuticals, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2014, 2016
Figure 68: Alder BioPharmaceuticals, Inc., Research and Development Cost, 2016 and 2015 (Thousands)
Figure 69: Eli Lilly and Company, Net Sales, by Region, 2016
Figure 70: Eli Lilly and Company, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 71: Eli Lilly and Company, Breakdown of Net Sales, by Business Segment, 2016
Figure 72: Eli Lilly and Company, Research and Development Cost, 2016 and 2015 (US$ Mn)
Figure 73: Merck & Co., Inc., Net Sales, by Region, 2016
Figure 74: Merck & Co., Inc., Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
Figure 75: Merck & Co., Inc., Breakdown of Net Sales, by Business segment, 2016
Figure 76: Merck & Co., Inc., Research and Development Cost, 2016 and 2015 (US$ Bn)
Figure 77: Novartis AG, Net Sales, by Region, 2016
Figure 78: Novartis AG, Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
Figure 79: Novartis AG, Breakdown of Net Sales, by Business segment, 2016
Figure 80: Novartis AG, Breakdown of Net Sales, by Business Units, 2016
Figure 81: Bristol-Myers Squibb Company, Net Sales, by Region, 2016
Figure 82: Bristol-Myers Squibb Company, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 83: Bristol-Myers Squibb Company, Breakdown of Net Sales, by Business segment, 2016
Figure 84: Bristol-Myers Squibb Company, Research and Development Cost, 2016 and 2015 (US$ Mn)

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 5795
$ 8795

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top